Showing results (3221-3230 of 3,371) with videos related to

Sort By:
Pageof 338
ESC Heart Failure|September 18, 2025
Soluble urokinase plasminogen activator receptor and outcomes in HFpEF: A TOPCAT ancillary studyChristina G Hutten, Annika Tekumulla, Anis Ismail, et al.
ESC Heart Failure|September 17, 2025
Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MIDavid Erlinge, Stefan James, John Deanfield, et al.
ESC Heart Failure|September 8, 2025
A novel treatment score (QUAD score) to promote treatment optimization in heart failure with a reduced ejection fractionHenry Oluwasefunmi Savage, Jason N Dungu, Anthony Dimarco, et al.
ESC Heart Failure|June 12, 2025
Proteins associated with rehospitalization, mortality and diuretic resistance in acutely decompensated heart failureKenneth T Hubbell, Veena S Rao, Rebecca Scherzer, et al.
ESC Heart Failure|June 18, 2025
Interconnected pathways and emerging therapies in chronic kidney disease and heart failure: A comprehensive reviewJohann Bauersachs, Eri Toda Kato, Janani Rangaswami
ESC Heart Failure|June 18, 2025
Identification, characterisation and outcomes of pre-atrial fibrillation in heart failure with reduced ejection fractionAnna Helbitz, Ramesh Nadarajah, Lan Mu, et al.
ESC Heart Failure|June 21, 2025
Implementation of guidelines for intravenous iron therapy in heart failure patientsMilou Gamage, Aristomenis Manouras, Camilla Hage, et al.
ESC Heart Failure|February 16, 2024
Tyrosine to threonine ratio was related to heart failure with reduced or mildly reduced ejection fractionQing Fen Zhou, Fan Yang, Yang Dai, et al.
ESC Heart Failure|February 19, 2024
Chlorogenic acid attenuates cardiac hypertrophy via up-regulating Sphingosine-1-phosphate receptor1 to inhibit endoplasmic reticulum stressPing Ping, Ting Yang, Chaoxue Ning, et al.
ESC Heart Failure|March 5, 2024
Epidemiology and risk factors for hyperkalaemia in heart failureDiederick E Grobbee, Gerasimos Filippatos, Nihar R Desai, et al.
Pageof 338